Paula Rossignoli
Universidade Positivo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paula Rossignoli.
Revista Brasileira De Ciencias Farmaceuticas | 2008
José Benedito de França Filho; Cassyano Januário Correr; Paula Rossignoli; Ana Carolina Melchiors; Fernando Fernandez-Llimos; Roberto Pontarolo
The present study aimed to assess structure and process quality indicators in community pharmacies in Santa Catarina (Brazil), and also the profile of pharmacists regarding their attitudes and perceptions of pharmaceutical care and professional satisfaction. A cross-sectional study was performed in 10% of Santa Catarina pharmacies randomly chosen. 258 community pharmacies were surveyed. 88.5% pharmacists were in office in the time of the interview. In average, they were 31 years old (SD=8.1) and mainly women (68%). A ratio of 1.4 (SD=0.7) pharmacists per pharmacy and 3.8 (SD=4.5) assistants existed. Only 11.4% pharmacies had an adequate structure for private caring patients. Despite having an average of more than 2 tertiary drug information sources, most of them were low quality. Activities mentioned by the majority of pharmacists were dispensing (98.2%), recording controlled drugs (90.8%), injections administration (85.1%), and helping patients on cash line (84.2%). Most of pharmacies in Santa Catarina (Brazil) do not have the adequate structure for implementing pharmaceutical care services. Barriers identified to implement those services were not different to those communicated in other countries.
Arquivos Brasileiros De Endocrinologia E Metabologia | 2009
Cassyano Januário Correr; Roberto Pontarolo; Astrid Wiens; Paula Rossignoli; Ana Carolina Melchiors; Rosana Bento Radominski; Fernando Fernandez-Llimos
OBJECTIVE: Assess economics results of Pharmacotherapeutic Follow-up (PF) in patients with diabetes mellitus type 2 in community pharmacies from additional Health system. METHODS: In a prospective clinic study, 161 patients were divided into two groups, of which only one group received PF for 12 months. From the results, we calculated data of effectiveness and costs. The primary endpoint was the economic evaluation PF by using an indicator of effectiveness (changes in glycated hemoglobin), which was related to the costs of pharmaceutical care. Secondary endpoints were values of blood pressure, waist circumference and body mass index of patients, also related to costs of pharmaceutical care. RESULTS: A real reduction of 1.3% of HbA1 was observed in the PF group, in comparison to control group. The annual cost of the reduction in 1% in HbA1 values in the PF group patients was
Pharmacy Practice (granada) | 2006
Josiane Poli Baldon; Cassyano Januário Correr; Ana Carolina Melchiors; Paula Rossignoli; Fernando Fernandez-Llimos; Roberto Pontarolo
45.15. This feature to improve the control of type 2 diabetic patients can be implemented with annual investments of about
Arquivos Brasileiros De Endocrinologia E Metabologia | 2008
Cassyano Januário Correr; Roberto Pontarolo; Ana Carolina Melchiors; Paula Rossignoli; Fernando Fernandez-Llimos; Rosana Bento Radominski
225.76 per patient, using PF and monitoring of blood glucose test. CONCLUSIONS: It is possible to reduce the HbA1 values to desired levels by using PF. This can be considered an additional resource for the attainment of metabolic control, resulting in this study a cost of
Arquivos Brasileiros De Cardiologia | 2008
Renata Berberi Schulz; Paula Rossignoli; Cassyano Januário Correr; Fernando Fernandez-Llimos; Plínio Marco de Toni
37.62 per patient, per year, to reduce 1% in the HbA1 values.
American Journal of Health-system Pharmacy | 2005
Ana Carolina Melchiors; Cassyano Januário Correr; Paula Rossignoli; Roberto Pontarolo; Fernando Fernandez-Llimos
The present study aimed to assess knowledge and attitudes of the pharmacists on dispensing drugs to pregnant women. Methods: Cross-sectional study in 150 community pharmacies randomly selected in Curitiba (Brazil). A closed end questionnaire with 25 questions were used, including dispensing scenarios containing risk types A, B, D or X and questions on pharmacist interaction with pregnant women, physicians, and information sources availability. Results: Pharmacists performed appropriately in 53% of the encounters. Lower success were associated to prednison and captopril (24.8% in both), end cases producing more doubts were captopril (31.7%) and simvastatin (30.7%). Most of the pharmacists state have advised drugs to pregnant women or contact to the physician to discuss about a prescription related with this issue. A Majority (64.4%) did not feel able to understand FDA risk classification and did not have trustable information sources in pharmacy. Conclusions: Pharmacists dispensing drugs in Curitiba are not able to interpret information on the use of drugs in pregnant women, and they don have reliable information sources on the use of dugs in pregnancy. However, they advice and counsel drugs to pregnant women and discuss with physicians therapeutic strategies.
Cadernos De Saude Publica | 2009
Cassyano Januário Correr; Roberto Pontarolo; Ana Carolina Melchiors; Rodrigo Augusto de Souza; Paula Rossignoli; Fernando Fernandez-Llimos
Seguimiento Farmacoterapéutico | 2004
Cassyano Januário Correr; Paula Rossignoli; Rodrigo Souza e; Roberto Pontarolo
Pharmacy Practice (internet) | 2006
Josiane Poli Baldon; Cassyano Januário Correr; Ana Carolina Melchiors; Paula Rossignoli; Fernando Fernandez-Llimos; Roberto Pontarolo
Seguimiento Farmacoterapéutico | 2005
Paula Rossignoli; Fernando Fernández-Llimós Somoza; Cassyano Januário Correr; Ana Carolina Melchiors